CHF 1537
Latest Information Update: 18 Oct 2007
At a glance
- Originator Chiesi Farmaceutici
- Class Antiasthmatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 31 Dec 2003 Phase-I clinical trials in Asthma in Italy (unspecified route)
- 25 Feb 2003 Preclinical trials in Asthma in Italy (unspecified route)